Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study

DSpace Repository

Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study

Author: Plett, Helmut; Filippova, Olga T.; Garbi, Annalisa; Kommoss, Stefan; Rosendahl, Mikkel; Langstraat, Carrie; Phadnis, Saurabh; Muallem, Mustafa Zelal; Baert, Thais; Chi, Dennis S.; Aletti, Giovanni Damiano; Taran, Florin-Andrei; Ramspott, Jan Philipp; Zivanovic, Oliver; du Bois, Andreas; Sonoda, Yukio; Gardner, Ginger; Traut, Alexander; Roche, Kara Long; Harter, Philipp
Tübinger Autor(en):
Kommoss, Stefan
Ţăran, Florin-Andrei
Published in: Gynecologic Oncology (2020), Bd. 159, H. 2, S. 434-441
Verlagsangabe: Academic Press Inc Elsevier Science
Language: English
Full text: http://dx.doi.org/10.1016/j.ygyno.2020.08.028
ISSN: 1095-6859
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)